A chance diagnosis of appendiceal goblet-cell adenocarcinoma in acute appendicitis being treated by ileocecectomy plus partial right-hemicolectomy: A case report

一例在急性阑尾炎行回盲部切除术联合右半结肠部分切除术中偶然诊断出阑尾杯状细胞腺癌的病例报告

阅读:1

Abstract

INTRODUCTION AND IMPORTANCE: Appendiceal Goblet Cell Adenocarcinoma (GCA) is a renamed subtype of appendiceal adenocarcinoma. A proper management is required to improve the outcomes of the patients. We hereby reported a chance diagnosis of GCA presenting as acute appendicitis being treated by ileocecectomy plus partial right-hemicolectomy. CASE PRESENTATION: A 59-year old male complained of a right lower abdominal pain for 17 h on admission with a history of acute appendicitis. Physical examination revealed hyperactive bowel sound and right lower quadrant tenderness. CBC showed WBC and neutrophil elevation. Abdominal CT demonstrated an enlarged appendix with surrounding fat-stranding. A laparoscopic appendectomy was performed with the unexpected finding of GCA in the surgical specimen. Enhanced CT and colonoscopy were further performed to rule out metastasis. An ileocecectomy plus partial right-hemicolectomy was operated to resect the distal ileum and the proximal ascending colon both about 10 cm with the cecum. The pathology revealed that the ileocecal subserosa was invaded. The patient was then referred to the oncology department for 5-FU-based chemotherapy. CLINICAL DISCUSSION: GCA requires proper treatment. The diagnosis can be challenging due to the unspecific clinical manifestations, and is depending on pathology in the cases of appendicitis after appendectomy. Though right-hemicolectomy should remain as the standard treatment, the enhanced CT and colonoscopy are necessary for further evaluation. Our case has chosen the ileocecectomy plus partial right-hemicolectomy based on the enhanced CT and colonoscopy ruling out metastasis. CONCLUSION: The case highlights the ileocecectomy plus partial right-hemicolectomy to treat GCA on the specific preoperative evaluation ruling out metastasis and followed by the recommendation of 5-FU-based chemotherapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。